Jennifer E Munt, Sandra Henein, Cameron Adams, Ellen Young, Yixuan J Hou, Helen Conrad, Deanna Zhu, Stephanie Dong, Nurgun Kose, Boyd Yount, Rita M Meganck, Long Ping V Tse, Guillermina Kuan, Angel Balmaseda, Michael J Ricciardi, David I Watkins, James E Crowe, Eva Harris, Aravinda M DeSilva, Ralph S Baric
The envelope (E) glycoprotein is the primary target of type-specific (TS) neutralizing antibodies (nAbs) after infection with any of the four distinct dengue virus serotypes (DENV1-4). nAbs can be elicited to distinct structural E domains (EDs) I, II, or III. However, the relative contribution of these domain-specific antibodies is unclear. To identify the primary DENV3 nAb targets in sera after natural infection or vaccination, chimeric DENV1 recombinant encoding DENV3 EDI, EDII, or EDIII were generated...
October 25, 2023: Cell Host & Microbe